Published: Jul 16, 2025, 11:14 IST | Updated: Jul 16, 2025, 11:14 IST
India is strengthening its position in the global pharma supply chain, even as the U.S. considers heavy tariffs on imported drugs. For global drugmakers, outsourcing to India remains a cost-effective option—cutting manufacturing costs by almost 55% compared to doing the same work in the U.S.